An interventional study of Acupuncture therapy and Laparoscopic Surgery in Gastrointestinal Carcinoma and Pain, sponsored by Xiaonan Cui. Completed. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-01-25.
Sponsored by Xiaonan Cui · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Clinical trial on acupuncture adjuvant treatment in the pain after the surgery of gastrointestinal carcinoma. Gastrointestinal cancer patients are diagnosed by pathology or cell biology. Patients are randomized into 2 groups: The control group receive normal treatment only, the experimental group receive acupuncture therapy besides normal treatment. Clinical evaluation is based on the observation of the pain degree and life quality improvement. Blood biochemistry tests mainly include Prostaglandin E2(PGE2),5-hydroxytryptamine(5-HT), histamine(HIS), malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), adrenaline, nor-adrenaline, tumor necrosis factor (TNF)-α, cell flow cytometry on Th1, Th2, Th17, Treg cytokines as well as serum cortisol, estradiol (female), progesterone (female), testosterone (male) etc.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
This study's enrollment of 60 is close to the median of 66 across 8,512 interventional studies indexed under Pain.
Browse Pain studies →Xiaonan Cui is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
This group receives normal treatment after surgery,with no acupuncture.
Procedure: Laparoscopic Surgery
This group receives acupuncture therapy besides normal treatment after surgery. The acupuncture therapy starts after 24 hours of surgery, 1 time a day, 30 minutes every time, until the fifth day.
Device: Acupuncture therapy · Procedure: Laparoscopic Surgery
Pain degree change after surgery, Graded according to Numerical Rating Scale(NRS)
Time frame: day 1, day 2, day 3, day 4, day 5, day 6, day 7 after surgery
Assessing the quality of life(QOL) change in 4 grades and recording: appetite, mental state, sleep, fatigue, attitude towards treatment, daily life ability
Time frame: day 1, day 2, day 3, day 4, day 5, day 6, day 7 after surgery
Prostaglandin E2(PGE2) in blood
Time frame: day 2,day 7 after surgery
Estradiol(Female) in blood
Time frame: day 2, day 7 after surgery
Th1/Th2 in blood
Time frame: day 2, day 7 after surgery
5-Hydroxytryptamine(5-HT) in blood
Time frame: day 2,day 7 after surgery
Histamine(HIS) in blood
Time frame: day 2,day 7 after surgery
Th17/Treg in blood
Time frame: day 2, day 7 after surgery
Testosterone(Male) in blood
Time frame: day 2,day 7 after surgery
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Aug 2016 to primary completion in Jan 2019, 29 months.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 29 months is above that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Xiaonan Cui